TelyRx Announces Voting Results from Annual General Meeting of Shareholders

TelyRx (OTCQX:TELYF) reported voting results from its June 15, 2026 Annual Meeting of Shareholders.

Rhea-AI Summary

TelyRx (OTCQX:TELYF) reported voting results from its June 15, 2026 Annual Meeting of Shareholders. All nominated directors were elected and the additional resolution submitted to shareholders was approved.

Votes for nominees ranged from 8,788,172 (69.42%) for Michael Handler to 12,659,534 (100%) for Andrew Brandt.

Argus Jun 17 session

+15.29% close to close Open Argus

Details

News Market Reaction – TELYF

On Jun 17, the first trading day after this news, TELYF closed 15.29% above the previous close.

Data tracked by StockTitan Argus for the Jun 17 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the "Meeting"), has been elected. In addition, the other resolution put to vote at the Meeting was passed.

The detailed results of the vote for the election of directors at the Meeting are set out below.

Nominee	Votes For (1)
	No.	%
Michael Handler	8,788,172	69.42%
Vanessa Slowey	9,188,172	72.58%
Robert Sean Foley	9,188,172	72.58%
Kenneth Bernard	9,188,172	72.58%
Ransom Langford	9,188,172	72.58%
Andrew Brandt	12,659,534	100.00%

 

⁽¹⁾ Withheld votes represent the balance of votes cast in respect of each nominee.

About TelyRx Holdings Inc.

TelyRx is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform connecting patients with independent, state-licensed providers to access over 450 everyday medications across 48 U.S. states and territories. The company fulfills prescriptions through its licensed retail pharmacies and offers fast, convenient delivery of medications directly to patients' doors.

For additional information, visit www.telyrx.com or contact:

Neil Weber
Investor Relations
(647) 222-0574
investors@telyrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301644

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TelyRx (TELYF) announce about the 2026 annual meeting voting results?

TelyRx announced that all director nominees were elected and the other resolution at the June 15, 2026 meeting passed. According to TelyRx, shareholder support levels for nominees ranged from 69.42% of votes cast to 100% support for Andrew Brandt.

Which directors were elected at the TelyRx (TELYF) Annual Meeting on June 15, 2026?

Michael Handler, Vanessa Slowey, Robert Sean Foley, Kenneth Bernard, Ransom Langford, and Andrew Brandt were elected as directors. According to TelyRx, each nominee received more votes for than withheld, with Brandt receiving 12,659,534 votes, representing 100% of votes cast.

What voting percentages did TelyRx (TELYF) director nominees receive at the 2026 shareholder meeting?

Director support ranged from 69.42% to 100% of votes cast at the June 15, 2026 meeting. According to TelyRx, Michael Handler received 69.42% support, several nominees received 72.58%, and Andrew Brandt received 100% support with 12,659,534 votes for.

How many votes did Andrew Brandt receive in the TelyRx (TELYF) 2026 director election?

Andrew Brandt received 12,659,534 votes for his election, representing 100.00% of votes cast. According to TelyRx, this was the highest recorded support among nominees in the 2026 Annual Meeting director elections, with no withheld votes reported for Brandt.

Were all resolutions approved at the TelyRx (TELYF) June 15, 2026 shareholder meeting?

Yes, all resolutions presented, including director elections, were approved at the June 15, 2026 meeting. According to TelyRx, each nominated director was elected and the additional resolution put to a vote at the Annual Meeting was also passed by shareholders.